[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MSollender Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1063180083769176064.png) Michelle Solly [@MSollender](/creator/twitter/MSollender) on x 13.2K followers
Created: 2025-07-22 20:13:13 UTC

$ABVX XX mg once-daily dose of obefazimod led to a compelling pooled  XXXX% (p<0.0001) placebo-adjusted clinical remission rate at Week X  in the ABTECT-1 (Study 105) and ABTECT-2 (Study 106) trials.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947751810607026547/c:line.svg)

**Related Topics**
[$mngl](/topic/$mngl)
[$abvx](/topic/$abvx)

[Post Link](https://x.com/MSollender/status/1947751810607026547)